Home Categories API Orlistat
A6562412

Orlistat , >97.0%(HPLC) , 96829-58-2

Synonym(s):
(−)-Tetrahydrolipstatin;N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester;Orlistat;Ro-18-0647

CAS NO.:96829-58-2

Empirical Formula: C29H53NO5

Molecular Weight: 495.73

MDL number: MFCD05662360

EINECS: 639-755-1

Pack Size Price Stock Quantity
100MG RMB31.20 In Stock
250MG RMB39.20 In Stock
1G RMB56.80 In Stock
5G RMB100.00 In Stock
25G RMB476.00 In Stock
100G RMB1268.00 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: <50 °C
Boiling point: 615.9±30.0 °C(Predicted)
alpha  D20 -32.0° (c = 1 in chloroform)
Density  0.976±0.06 g/cm3(Predicted)
storage temp.  2-8°C
solubility  DMSO: 19 mg/mL
form  solid
pka 14.59±0.23(Predicted)
color  white
Merck  14,6869
Stability: Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 1 week.
InChIKey AHLBNYSZXLDEJQ-FWEHEUNISA-N
SMILES C(O[C@H](C[C@H]1[C@H](CCCCCC)C(=O)O1)CCCCCCCCCCC)(=O)[C@H](CC(C)C)NC=O
CAS DataBase Reference 96829-58-2(CAS DataBase Reference)

Description and Uses

Orlistat is a digestive lipase inhibitor. It inhibits diacylglycerol lipase α (DAGLα), DAGLβ, α/β-hydrolase domain-containing protein 12 (ABHD12), ABHD16A, and platelet-activating factor acetylhydrolase (PAF-AH; IC50s = 0.06, 0.1, 0.08, 0.03, and 0.05 μM, respectively), as well as pancreatic lipase and hormone-sensitive lipase (IC50s = 0.65 and 2.1 μg/ml, respectively) but does not inhibit fatty acid amide hydrolase (FAAH) or KIAA1363 (IC50s = >100 μM for both). Orlistat decreases ionomycin-induced production of the endocannabinoid 2-arachidonoyl glycerol (2-AG) in N18TG2 murine neuroblastoma cells when used at a concentration of 1 μM. It also inhibits fatty acid synthase (FASN; Kiapp = ~0.1 μM for the human enzyme) and the proliferation of PC3 prostate cancer cells in a concentration-dependent manner. Orlistat (10 mg/kg) decreases serum cholesterol levels and total body weight in a mouse model of obesity induced by a high-fat diet. Formulations containing orlistat have been used in the treatment of adult obesity.

Orlistat is an antiobesity agent. Orlistat is an pancreatic lipase inhibitor.

Safety

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302-H412
Precautionary statements  P273
WGK Germany  3
RTECS  OH3167600
HS Code  29322090
Hazardous Substances Data 96829-58-2(Hazardous Substances Data)

RELATED PRODUCTS